Reimagining Regional Anesthesia Is B. Braun Medical’s Focus at ASRA
April 04 2017 - 8:00AM
B. Braun Melsungen AG and Royal Philips (NYSE:PHG) (AEX:PHIA) will
unveil a new strategic alliance at the B. Braun Medical Inc. booth
at the American Society of Regional Anesthesia (ASRA) and Acute
Pain Medicine’s 42nd annual conference. The new alliance with B.
Braun, the global leader in regional anesthesia and pain
management, and Philips, an industry leader in image-guided therapy
solutions, aims to make regional anesthesia easier and more
effective to perform, leading to enhanced patient care and hospital
efficiency.
“B. Braun and Philips have joined forces to reimagine regional
anesthesia, a rapidly growing alternative to general anesthesia
that targets specific areas of a patient’s body that will undergo
surgery or other medical procedures,” said Brad Lane, Vice
President of Critical Care Marketing at B. Braun Medical. “Regional
anesthesia’s advantages may lead to faster postsurgical recoveries,
so patients may leave the hospital sooner.”
B. Braun and Philips are jointly developing solutions to support
anesthesiologists and hospitals. As a platform to implement the
alliance’s innovations, the Xperius™ ultrasound system will be
previewed at the ASRA conference. Xperius is designed to be mobile,
ergonomic and have an intuitive user interface. Xperius’ anatomical
imaging complements B. Braun’s regional block needle portfolio and
addresses the continued need for enhanced needle visualization and
guidance.
Visitors to B. Braun’s booth (#307) will be able to see the
Stimuplex® and Ultraplex 360® needles, including the new Stimuplex®
Ultra 360® and Contiplex® Ultra 360®. The regional block needle
portfolio includes stimulating, non-stimulating and echogenic
single shot and continuous needles to match all clinical
preferences.
B. Braun will offer an educational presentation based on the
Sheffield Hallam University Study “Regional Block Needles: A Matter
of Feel and Brightness.” The presentation will be made by study
coauthor Dawn Cooper, PhD. The presentation will demonstrate
evidence that the Stimuplex Ultra 360 is preferred by physicians
for tactile qualities. Dr. Cooper is a Research Fellow at Sheffield
Hallam University, Netherlands. The presentation by Dr. Cooper, who
also is a Research Analyst for B. Braun UK, will start at 9:45 a.m.
and 3:45 p.m. on April 7 and at 9:30 a.m. on April 8 in the B.
Braun booth #307. Preregistration is not required.
Also at the ASRA show, being held April 6 to 8 at the Marriott
Marquis in San Francisco, B. Braun representatives will be
available in booth to discuss the B. Braun and Philips alliance,
the Xperius ultrasound system, the regional anesthesia needle
portfolio and NRFit™ connectors.
NRFit connectors are small bore connectors intended to reduce
the risk of accidental misconnections of neuraxial devices with
those used for IV, enteral and other applications. All health care
facilities in the United States are expected to eventually convert
to these types of neuraxial products to improve patient safety and
meet the ISO standard. California is the first state to mandate the
conversion in 2017 to ISO 80369-7 compliant connectors.
About B. Braun B. Braun Medical Inc., a leader
in infusion therapy and pain management, develops, manufactures,
and markets innovative medical products and services to the health
care industry. The company is committed to eliminating preventable
treatment errors and enhancing patient, clinician and environmental
safety. B. Braun Medical is headquartered in Bethlehem, Pa., and is
part of the B. Braun Group of Companies in the U.S., which includes
B. Braun Interventional Systems, Aesculap® and CAPS®.
Globally, the B. Braun Group of Companies employs more than
58,000 employees in 64 countries. Guided by its Sharing Expertise®
philosophy, B. Braun continuously exchanges knowledge with
customers, partners and clinicians to address the critical issues
of improving care and lowering costs. To learn more about B. Braun
Medical, visit www.BBraunUSA.com.
Contact:
Jason Ford
B. Braun Medical Inc.
610.997.4722
jason.ford@bbraun.com
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Apr 2023 to Apr 2024